Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: A meta-analysis

JAMA

Volumn 300, Issue 1, 2008, Pages 71-80

  O'Donoghue, Michelle ^a,b   Boden, William E ^c   Braunwald, Eugene ^a   Cannon, Christopher P ^a   Clayton, Tim C ^d   De Winter, Robbert J ^e   Fox, Keith A A ^f   Lagerqvist, Bo ^g   McCullough, Peter A ^h   Murphy, Sabina A ^a   Spacek, Rudolf ⁱ   Swahn, Eva ^j   Wallentin, Lars ^g   Windhausen, Fons ^e   Sabatine, Marc S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BUFFALO GENERAL HOSPITAL   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h WILLIAM BEAUMONT HOSPITAL   (United States)

ⁱ Na Franti ku Hospital   (Czech Republic)

^j LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN;

ACUTE CORONARY SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DISEASE MARKER; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; INTERMETHOD COMPARISON; MALE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 46349083643     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.1.71     Document Type: Review

References (40)

1. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study: FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999;354(9180):708-715.
2. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial: Randomized Intervention Trial of unstable Angina. Lancet. 2002;360(9335):743-751.
3. Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293(23):2908-2917.
4. Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol. 2001;38(1):41-48.
5. Clayton TC, Pocock SJ, Henderson RA, et al. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? the impact of gender in the RITA 3 trial. Eur Heart J. 2004;25(18):1641-1650.
6. Glaser R, Herrmann HC, Murphy SA, et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 2002;288(24):3124-3129.
7. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879-1887.
8. de Winter RJ, Windhausen F, Cornel JH, et al; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353(11):1095-1104.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
10. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial: Thrombolysis in Myocardial Ischemia. Circulation. 1994;89(4):1545-1556.
11. McCullough PA, O'Neill WW, Graham M, et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: results of the Medicine versus Angiography in Thrombolytic Exclusion (MATE) trial. J Am Coll Cardiol. 1998;32(3):596-605.
12. Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. Am J Cardiol. 1978;42(5):839-848.
13. Brown CA, Hutter AM Jr, DeSanctis RW, et al. Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: results of in-hospital and chronic mortality and morbidity. Am Heart J. 1981;102(6 pt 1):959-964.
14. Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris: results of a Veterans Administration Cooperative Study. N Engl J Med. 1987;316(16):977-984.
15. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction: SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. BMJ. 1991;302(6776):555-560.
16. Scott SM, Deupree RH, Sharma GV, Luchi RJ; VA Study of Unstable Angina. 10-year results show duration of surgical advantage for patients with impaired ejection fraction. Circulation. 1994;90(5 pt 2):II120-II123.
17. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI): DANish trial in Acute Myocardial Infarction. Circulation. 1997;96(3):748-755.
18. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998;338(25):1785-1792.
19. Michalis LK, Stroumbis CS, Pappas K, et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery: invasive versus conservative strategy (TRUCS Study). Eur Heart J. 2000;21(23):1954-1959.
20. Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial: the VINO study. Eur Heart J. 2002;23(3):230-238.
21. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA. 2003;289(9):1117-1123.
22. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290(12):1593-1599.
23. Swahn E. OASIS 5: Worse Outcome With an Invasive Strategy Among Women With Non STElevation Acute Coronary Syndromes. Vienna, Austria: ESC Congress; 2007.
24. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1-e157.
25. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J. 2007;28(13):1598-1660.
26. Bolooki H, Vargas A, Green R, Kaiser GA, Ghahramani A. Results of direct coronary artery surgery in women. J Thorac Cardiovasc Surg. 1975;69(2):271-277.
27. Khan SS, Nessim S, Gray R, Czer LS, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med. 1990;112(8):561-567.
28. Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients: differences between men and women. Circulation. 1993;88(5 pt 2):II79-II86.
29. O'Connor GT, Morton JR, Diehl MJ, et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery: the Northern New England Cardiovascular Disease Study Group. Circulation. 1993;88(5 pt 1):2104-2110.
30. Sullivan AK, Holdright DR, Wright CA, et al. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308(6933):883-886.
31. Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB: TIMI Investigators: Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1997;30(1):141-148.
32. Jacobs AK, Kelsey SF, Brooks MM, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1998;98(13):1279-1285.
33. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis. 2004;46(4):305-319.
34. Humphries KH, Gao M, Pu A, Lichtenstein S, Thompson CR. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol. 2007;49(14):1552-1558.
35. Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 2005;366(9489):914- 920.
36. Cannon RO III, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation. 1992;85(3):883-892.
37. DeSanctis RW. Clinical Manifestations of Coronary Artery Disease: Chest Pain in Women. Greenwich, CT: Le Jacq Communications Inc; 1993.
38. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266(1):93-98.
39. Rothwell PM. Treating individuals 2: subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365(9454):176-186.
40. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ. 1997;315(7109):617-619.